Novel Antischizophrenia Treatments

Editors:

ISBN: 978-3-642-25757-5 (Print) 978-3-642-25758-2 (Online)

Table of contents (14 chapters)

  1. Front Matter

    Pages i-x

  2. No Access

    Book Chapter

    Pages 1-10

    Clinical Instruments to Evaluate and Guide Treatment in Schizophrenia

  3. No Access

    Book Chapter

    Pages 11-37

    Cognitive Impairment in Schizophrenia

  4. No Access

    Book Chapter

    Pages 39-79

    Behavioral Animal Models to Assess Pro-cognitive Treatments for Schizophrenia

  5. No Access

    Book Chapter

    Pages 81-111

    Towards Medication-Enhancement of Cognitive Interventions in Schizophrenia

  6. No Access

    Book Chapter

    Pages 113-145

    Mutant Mouse Models in Evaluating Novel Approaches to Antipsychotic Treatment

  7. No Access

    Book Chapter

    Pages 147-165

    5-HT2C Agonists as Therapeutics for the Treatment of Schizophrenia

  8. No Access

    Book Chapter

    Pages 167-210

    The Role of Dopamine D3 Receptors in Antipsychotic Activity and Cognitive Functions

  9. No Access

    Book Chapter

    Pages 211-232

    Nicotinic Mechanisms in the Treatment of Psychotic Disorders: A Focus on the α7 Nicotinic Receptor

  10. No Access

    Book Chapter

    Pages 233-265

    Muscarinic Mechanisms in Psychotic Disorders

  11. No Access

    Book Chapter

    Pages 267-295

    Glutamatergic Synaptic Dysregulation in Schizophrenia: Therapeutic Implications

  12. No Access

    Book Chapter

    Pages 297-365

    Metabotropic Glutamate Receptors for New Treatments in Schizophrenia

  13. No Access

    Book Chapter

    Pages 367-399

    Glycine Transport Inhibitors in the Treatment of Schizophrenia

  14. No Access

    Book Chapter

    Pages 401-417

    Nicotinic Receptors and Functional Regulation of GABA Cell Microcircuitry in Bipolar Disorder and Schizophrenia

  15. No Access

    Book Chapter

    Pages 419-442

    Development of Disease-Modifying Treatment of Schizophrenia

  16. Back Matter

    Pages 443-455